四川新斯顿制药股份有限公司

Manufacturer / marketing-authorisation holder

四川新斯顿制药股份有限公司 — 75 products across 1 markets, 2 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

四川新斯顿制药股份有限公司 — 75 productos en 1 mercados, 2 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

四川新斯顿制药股份有限公司 —— 共 75 个产品,覆盖 1 个市场、2 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

75 products · 1 markets · 2 brand names

75 productos · 1 mercados · 2 marcas

75 个产品 · 1 个市场 · 2 个品牌名

Products by country

CN (75 records)

Source: code.nhsa.gov.cn

BrandActive ingredient(s)Form
—间苯三酚injection
—阿加曲班injection
—阿加曲班injection
—甲钴胺tablet
—甲钴胺tablet
—甲钴胺tablet
—甲钴胺tablet
—甲钴胺tablet
—甲钴胺tablet
—甲钴胺tablet
—甲钴胺tablet
—腺苷钴胺capsule
—腺苷钴胺capsule
—米力农injection
—米力农injection
—盐酸乌拉地尔injection
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星tablet
—左氧氟沙星injection
—左氧氟沙星injection
—左氧氟沙星injection
—奥硝唑injection
—奥硝唑injection
—奥硝唑injection
—奥硝唑injection
—酮咯酸氨丁三醇injection
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—塞来昔布capsule
—盐酸美金刚tablet
—盐酸美金刚tablet
—盐酸美金刚tablet
—盐酸美金刚tablet
—盐酸美金刚tablet
—氯雷他定tablet
—氯雷他定tablet
—氯雷他定tablet
—氯雷他定tablet
—氯雷他定tablet
—氯雷他定tablet

Showing the first 60 of 75 products (ordered by country).

Mostrando los primeros 60 de 75 productos (orden por país).

仅显示前 60 / 75 个产品(按国家排序)。

Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.